BELLINI, MICHELA

BELLINI, MICHELA  

DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE  

Mostra records
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.017 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands 01 - Articolo su rivista 2013 Fiandra, LMAZZUCCHELLI, SERENACOLOMBO, MIRIAMBELLINI, MICHELAPROSPERI, DAVIDE +
Delivering colloidal nanoparticles to mammalian cells: a nano-bio interface perspective 01 - Articolo su rivista 2014 VERDERIO, PAOLOAVVAKUMOVA, SVETLANABELLINI, MICHELACOLOMBO, MIRIAMGALBIATI, ELISABETTAMAZZUCCHELLI, SERENASANTINI, BENEDETTAPROSPERI, DAVIDE +
Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells 01 - Articolo su rivista 2014 BELLINI, MICHELAMAZZUCCHELLI, SERENAGALBIATI, ELISABETTAFiandra, LRIZZUTO, MARIA ANTONIETTACOLOMBO, MIRIAMTORTORA, PAOLOPROSPERI, DAVIDE +
“Blind” targeting in action: From phage display to breast cancer cell targeting with peptide-gold nanoconjugates 01 - Articolo su rivista 2016 GALBIATI, ELISABETTABELLINI, MICHELAAVVAKUMOVA, SVETLANAPROSPERI, DAVIDE +
Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity 01 - Articolo su rivista 2017 BELLINI, MICHELAFIANDRA, LUISARIZZUTO, MARIA ANTONIETTAPROSPERI, DAVIDE +
H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells 01 - Articolo su rivista 2017 Pandolfi, LauraBellini, MichelaAvvakumova, SvetlanaBertolini, Jessica ArmidaRizzuto, Maria AntoniettaColombo, MiriamProsperi, Davide +
Metronomic nanocaged doxorubicin prevents chemoresistance and cardiotoxicity in breast cancer 02 - Intervento a convegno 2017 Bellini M.Rizzuto M. A.Prosperi D. +
H-Ferritin-nanocaged olaparib: A promising choice for both BRCA-mutated and sporadic triple negative breast cancer 01 - Articolo su rivista 2017 Bellini, M.Rizzuto, M. A.Prosperi, D. +
Development of apoferritin nanoparticles for chemotherapeutic delivery and drug resistance overcoming in breast cancer models 07 - Tesi di dottorato Bicocca post 2009 2017 BELLINI, MICHELA
Olaparib nanoformulation in H-Ferritin for the triple negative breast cancer treatment 02 - Intervento a convegno 2018 Bellini M.Prosperi D. +
Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity 01 - Articolo su rivista 2018 Riva, BenedettaBellini, MichelaVerderio, PaoloColzani, BarbaraAvvakumova, SvetlanaRizzuto, Maria AntoniettaColombo, MiriamProsperi, Davide +
Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells 01 - Articolo su rivista 2019 Avvakumova S.Pandolfi L.Bellini M.Galbiati E.Rizzuto M. A.Colombo M.Prosperi D. +
Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model 01 - Articolo su rivista 2020 Bellini M.Prosperi D. +
Engineered Ferritin Nanoparticles for the Bioluminescence Tracking of Nanodrug Delivery in Cancer 01 - Articolo su rivista 2020 Bellini M.Riva B.Rizzuto M. A.Salvioni L.Colombo M.Mingozzi F.Marongiu L.Frascotti G.Prosperi D.Fiandra L. +
MnO Nanoparticles Embedded in Functional Polymers as T1 Contrast Agents for Magnetic Resonance Imaging 01 - Articolo su rivista 2020 Mauri M.Collico V.Morelli L.Penaranda Avila J.Bellini M.Rotem R.Simonutti R.Colombo M.Prosperi D. +
Development of an Effective Tumor-Targeted Contrast Agent for Magnetic Resonance Imaging Based on Mn/H-Ferritin Nanocomplexes 01 - Articolo su rivista 2021 Tullio C.Salvioni L.Bellini M.Fiandra L.D'Arienzo M.Garbujo S.Rotem R.Testa F.Prosperi D.Colombo M. +
Evaluation of tfr-1 expression in feline mammary cancer and in vitro antitumor efficacy study of doxorubicin-loaded h-ferritin nanocages 01 - Articolo su rivista 2021 Prosperi D.Rizzuto M. A.Bellini M. +